Skip to main content
Clinical Trials/NCT01599026
NCT01599026UnknownNot Applicable

Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function

Ain Shams Maternity Hospital1 site in 1 country120 target enrollmentStarted: April 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
120
Locations
1
Primary Endpoint
To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control.

Study Overview

Brief Summary

Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers

Detailed Description

Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers specially during third trimester of pregnancy

Study Design

Study Type
Observational
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
20 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • singleton pregnancy
  • gestational age 36 weeks

Exclusion Criteria

  • congenital anomalies
  • obstetric complications
  • medical disorders other than diabetes

Outcomes

Primary Outcomes

To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control.

Time Frame: one year

To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control during third trimester of pregnancy.

Secondary Outcomes

  • cardiac function in infant of diabetic mother(one year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

heba mohamed

Cardiac septal hypertrophy in the fetus of diabetic mother and its effect on postnatal cardiac function

Ain Shams Maternity Hospital

Study Sites (1)

Loading locations...

Similar Trials